Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49173) 49173
Publication (4756) 4756
Newsletter (3675) 3675
Book Review (738) 738
Book Chapter (283) 283
Conference Proceeding (86) 86
Dissertation (81) 81
Book / eBook (33) 33
Magazine Article (20) 20
Newspaper Article (20) 20
Reference (11) 11
Data Set (6) 6
Paper (2) 2
Transcript (2) 2
Web Resource (2) 2
Government Document (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (23298) 23298
humans (23013) 23013
index medicus (20028) 20028
male (18802) 18802
angiotensin (15815) 15815
rats (12539) 12539
hypertension (11543) 11543
female (11096) 11096
angiotensin-ii (7893) 7893
angiotensin ii (7766) 7766
peripheral vascular disease (6572) 6572
middle aged (6276) 6276
renin-angiotensin system (6275) 6275
pharmacology & pharmacy (6215) 6215
mice (5675) 5675
research (5521) 5521
cardiac & cardiovascular systems (5322) 5322
blood-pressure (5246) 5246
blood pressure - drug effects (5136) 5136
hypertension - drug therapy (5014) 5014
angiotensin ii - pharmacology (4991) 4991
angiotensin-converting enzyme inhibitors - therapeutic use (4990) 4990
physiology (4962) 4962
aged (4897) 4897
blood pressure (4608) 4608
expression (4568) 4568
rats, sprague-dawley (4347) 4347
angiotensin ii type 1 receptor blockers - therapeutic use (4307) 4307
adult (4177) 4177
oxidative stress (4128) 4128
risk factors (3717) 3717
urology & nephrology (3580) 3580
cells, cultured (3536) 3536
hypertension - physiopathology (3442) 3442
analysis (3395) 3395
antihypertensive agents - therapeutic use (3362) 3362
physiological aspects (3310) 3310
angiotensin ii - metabolism (3242) 3242
biochemistry & molecular biology (3160) 3160
angiotensin ii type 1 receptor blockers - pharmacology (3155) 3155
endocrinology & metabolism (3117) 3117
renin-angiotensin system - drug effects (3101) 3101
cell biology (3060) 3060
heart failure (3004) 3004
diabetes (2899) 2899
treatment outcome (2861) 2861
angiotensin receptor antagonists (2842) 2842
enzymes (2835) 2835
disease models, animal (2823) 2823
rats, wistar (2763) 2763
losartan (2751) 2751
renin-angiotensin system - physiology (2710) 2710
angiotensin-converting enzyme (2626) 2626
inflammation (2588) 2588
angiotensin-converting enzyme inhibitors - pharmacology (2571) 2571
activation (2558) 2558
receptor (2536) 2536
medicine & public health (2510) 2510
dose-response relationship, drug (2507) 2507
signal transduction (2463) 2463
article (2460) 2460
health aspects (2434) 2434
receptor, angiotensin, type 1 - metabolism (2424) 2424
system (2406) 2406
fibrosis (2403) 2403
rodents (2402) 2402
tetrazoles - pharmacology (2377) 2377
time factors (2363) 2363
renin (2345) 2345
mortality (2293) 2293
gene expression (2264) 2264
heart-failure (2254) 2254
receptor, angiotensin, type 1 (2246) 2246
medicine (2209) 2209
drug therapy, combination (2177) 2177
heart (2176) 2176
losartan - pharmacology (2174) 2174
proteins (2174) 2174
antihypertensive agents - pharmacology (2119) 2119
medicine, research & experimental (2106) 2106
inhibition (2066) 2066
tetrazoles - therapeutic use (2029) 2029
drug therapy (1998) 1998
gene-expression (1992) 1992
hypertrophy (1992) 1992
myocardial-infarction (1991) 1991
nitric oxide (1986) 1986
receptors (1983) 1983
cardiology (1978) 1978
neurosciences (1961) 1961
aldosterone (1951) 1951
mice, inbred c57bl (1932) 1932
care and treatment (1928) 1928
cells (1910) 1910
atherosclerosis (1895) 1895
disease (1886) 1886
smooth-muscle-cells (1869) 1869
nitric-oxide (1844) 1844
reports (1811) 1811
kidney (1797) 1797
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51868) 51868
Japanese (367) 367
German (234) 234
Chinese (199) 199
Russian (110) 110
French (105) 105
Spanish (91) 91
Korean (37) 37
Italian (35) 35
Polish (28) 28
Portuguese (26) 26
Danish (16) 16
Czech (9) 9
Hungarian (9) 9
Swedish (7) 7
Turkish (7) 7
Norwegian (6) 6
Ukrainian (6) 6
Dutch (4) 4
Finnish (3) 3
Serbian (3) 3
Romanian (2) 2
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists
by Michel, Martin C and Foster, Carolyn and Brunner, Hans R and Liu, Lisheng
Pharmacological Reviews, ISSN 0031-6997, 2013, Volume 65, Issue 2, pp. 809 - 848
Angiotensin II type 1 receptor antagonists (ARBs) have become an important drug class in the treatment of hypertension and heart failure and the protection... 
ANION TRANSPORTING POLYPEPTIDE | ACTIVE METABOLITE E-3174 | HEALTHY MALE-VOLUNTEERS | SPONTANEOUSLY HYPERTENSIVE-RATS | PHARMACOLOGY & PHARMACY | HUMAN LIVER-MICROSOMES | PLASMA-PROTEIN BINDING | ISCHEMIC BRAIN-DAMAGE | THROMBOXANE A-INDUCED VASOCONSTRICTION | VASCULAR SMOOTH-MUSCLE | STAGE RENAL-DISEASE | Angiotensin II Type 1 Receptor Blockers - chemistry | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Diabetic Nephropathies - metabolism | Humans | Hypertension - drug therapy | Heart Failure - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Heart Failure - drug therapy | Hypertension - metabolism | Tissue Distribution | Animals | Drug Interactions | Receptor, Angiotensin, Type 1 - metabolism | Molecular Structure | Binding Sites | Diabetic Nephropathies - prevention & control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Disruption of the Ang II type 1 receptor promotes longevity in mice
by Benigni, Ariela and Corna, Daniela and Zoja, Carla and Sonzogni, Aurelio and Latini, Roberto and Salio, Monica and Conti, Sara and Rottoli, Daniela and Longaretti, Lorena and Cassis, Paola and Morigi, Marina and Coffman, Thomas M and Remuzzi, Giuseppe
Journal of Clinical Investigation, ISSN 0021-9738, 03/2009, Volume 119, Issue 3, pp. 524 - 530
The renin-angiotensin system plays a role in the etiology of hypertension and the pathophysiology of cardiac and renal diseases in humans. Ang II is the... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIFE-SPAN | OXIDATIVE STRESS | AT(1A) | ANGIOTENSIN-II | RESTRICTION | SIRTUINS | KIDNEY | SIRT1 | BLOOD-PRESSURE | SMALL-MOLECULE ACTIVATORS | Mice, Knockout - genetics | Up-Regulation | Vascular Diseases - prevention & control | Body Weight | Down-Regulation | Oxidative Stress - genetics | Vascular Diseases - genetics | Blood Glucose | Heart Diseases - prevention & control | Mitochondrial Proteins - genetics | Longevity - genetics | Energy Intake | Nicotinamide Phosphoribosyltransferase - genetics | Phenotype | Rotarod Performance Test | Animals | Sirtuin 3 | Adaptor Proteins, Signal Transducing - genetics | Mice | Sirtuins - genetics | Cytokines - genetics | Heart Diseases - genetics | Hypertension | Complications and side effects | Causes of | Genetic aspects | Research | Longevity | Renin-angiotensin system | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Angiotensin II type 1 receptor blockers
by Burnier, M
Circulation, ISSN 0009-7322, 02/2001, Volume 103, Issue 6, pp. 904 - 912
Heart failure | Hypertension | Antihypertensive agents | Angiotensin | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | AT RECEPTOR | COMBINATION THERAPY | ANTAGONIST LOSARTAN | antihypertensive agents | ESSENTIAL-HYPERTENSION EFFICACY | BLOOD-PRESSURE | CONVERTING-ENZYME-INHIBITOR | angiotensin | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | CANDESARTAN CILEXETIL | CONGESTIVE-HEART-FAILURE | hypertension | LOSARTAN POTASSIUM
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance
by Violin, Jonathan D and DeWire, Scott M and Yamashita, Dennis and Rominger, David H and Nguyen, Lisa and Schiller, Kevin and Whalen, Erin J and Gowen, Maxine and Lark, Michael W
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 572 - 579
Biased G protein-coupled receptor ligands engage subsets of the receptor signals normally stimulated by unbiased agonists. However, it is unclear whether... 
PATHWAYS | ACTIVATION | INTERNALIZATION | GRKS | ANTAGONIST | CONTRACTILITY | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | KINASE | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | RNA, Small Interfering - genetics | Humans | Myocardial Contraction - physiology | Myocardial Contraction - drug effects | Arrestins - genetics | Male | Extracellular Signal-Regulated MAP Kinases - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Arrestins - metabolism | Receptor, Angiotensin, Type 1 - genetics | Drug Interactions | Transfection | HEK293 Cells | src-Family Kinases - metabolism | Cardiovascular Physiological Phenomena - drug effects | Ventricular Function, Left - physiology | Blood Pressure - drug effects | Nitric Oxide Synthase Type III - metabolism | Focal Adhesion Kinase 1 - metabolism | Binding, Competitive | Angiotensin II - pharmacology | Angiotensin II - metabolism | Myocytes, Cardiac - cytology | Ventricular Function, Left - drug effects | Rats | Angiotensin II - analogs & derivatives | Oligopeptides - metabolism | Receptor, Angiotensin, Type 1 - agonists | Animals | Myocytes, Cardiac - drug effects | Signal Transduction - drug effects | Proto-Oncogene Proteins c-jun - metabolism | beta-Arrestins | Cell Line, Tumor | Signal Transduction - physiology | Mice | Oligopeptides - pharmacology | GTP-Binding Proteins - metabolism
Journal Article
Details down arrow
5. Full Text Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
by Eguchi, Satoru and Kawai, Tatsuo and Scalia, Rosario and Rizzo, Victor
Hypertension, ISSN 0194-911X, 05/2018, Volume 71, Issue 5, pp. 804 - 810
GROWTH-FACTOR RECEPTOR | INDUCED HYPERTROPHY | INTERNATIONAL UNION | ABDOMINAL AORTIC-ANEURYSM | CARDIOVASCULAR-SYSTEM | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | NECROSIS-FACTOR-ALPHA | DEPENDENT HYPERTENSION | ENDOPLASMIC-RETICULUM STRESS | COMMERCIAL ANTIBODIES LEADS | Cardiovascular Diseases - physiopathology | Humans | Male | Renin-Angiotensin System - physiology | Vascular Diseases - physiopathology | Hypertension - physiopathology | Mice, Knockout | Animals | Signal Transduction - drug effects | Receptor, Angiotensin, Type 1 - metabolism | Sensitivity and Specificity | Female | Models, Animal | Signal Transduction - physiology | Mice | Receptor, Angiotensin, Type 1 - drug effects | Muscle, Smooth, Vascular - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans‐inhibition
by Siddiquee, K and Hampton, J and McAnally, D and May, LT and Smith, LH
British Journal of Pharmacology, ISSN 0007-1188, 03/2013, Volume 168, Issue 5, pp. 1104 - 1117
This article is commented on by Goupil et al., pp. 1101‐1103 of this issue. Background and Purpose The apelin receptor (APJ) is often co‐expressed with the... 
apelin | angiotensin II | heterodimerization | GPCR | APJ receptor | AT1 receptor | allosterism | SUBTYPES | PROTEIN-COUPLED RECEPTORS | ROLES | SOMATOSTATIN | DOPAMINE | PHARMACOLOGY & PHARMACY | OPIOID RECEPTORS | APJ | OLIGOMERIZATION | BETA-ADRENERGIC RECEPTOR | Chemistry Techniques, Analytical | Receptors, G-Protein-Coupled - metabolism | Allosteric Regulation | Apelin Receptors | Humans | Protein Multimerization | Receptor, Angiotensin, Type 1 - metabolism | HEK293 Cells | Angiotensin II Type 1 Receptor Blockers - metabolism | Phosphates | Physiological aspects | Inositol | Depression, Mental | Angiotensin | Cardiovascular disease | Research Papers with Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Angiotensin-(1–7) suppresses hepatocellular carcinoma growth and angiogenesis via complex interactions of angiotensin II type 1 receptor, angiotensin II type 2 receptor and mas receptor
by Liu, Yanping and Li, Bin and Wang, Ximing and Li, Guishuang and Shang, Rui and Yang, Jianmin and Wang, Jiali and Zhang, Meng and Chen, Yuguo and Zhang, Yun and Zhang, Cheng and Hao, Panpan
Molecular Medicine, ISSN 1076-1551, 2015, Volume 21, Issue 1, pp. 626 - 636
We recently confirmed that angiotensin II (Ang II) type 1 receptor (AT(1)R) was overexpressed in hepatocellular carcinoma tissue using a murine hepatoma model.... 
TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INHIBITS GROWTH | CELL PROLIFERATION | MICROVESSEL DENSITY | TUMOR ANGIOGENESIS | CELL BIOLOGY | BREAST-CANCER | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | PROSTATE-CANCER | EXPRESSION | Phosphorylation | Apoptosis - drug effects | Humans | Neovascularization, Pathologic - pathology | Mitogen-Activated Protein Kinase 11 - metabolism | Receptor, Angiotensin, Type 1 - genetics | Carcinoma, Hepatocellular - drug therapy | Receptor, Angiotensin, Type 1 - biosynthesis | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - pathology | Gene Expression Regulation, Neoplastic - drug effects | Mitogen-Activated Protein Kinase 11 - genetics | Receptor, Angiotensin, Type 2 - genetics | Liver Neoplasms - genetics | Peptide Fragments - administration & dosage | Receptor, Angiotensin, Type 2 - biosynthesis | Angiotensin I - administration & dosage | Liver Neoplasms - drug therapy | Hep G2 Cells | Xenograft Model Antitumor Assays | Animals | Neovascularization, Pathologic - drug therapy | Carcinoma, Hepatocellular - pathology | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Mice
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
by Gamradt, Matthew and Judge, Daniel P and Klein, Erin C and ap Rhys, Colette M and Habashi, Jennifer P and Cohn, Ronald D and Lisi, Matthew T and Soleimani, Arshia A and van Erp, Christel and Loeys, Bart L and Ramirez, Francesco and Dietz, Harry C and Holm, Tammy M and Ward, Christopher W
Nature Medicine, ISSN 1078-8956, 02/2007, Volume 13, Issue 2, pp. 204 - 210
Skeletal muscle has the ability to achieve rapid repair in response to injury or disease. Many individuals with Marfan syndrome (MFS), caused by a deficiency... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUSCULAR-DYSTROPHY | MDX MICE | CELL BIOLOGY | PATHOGENESIS | SKELETAL-MUSCLE | MARFAN-SYNDROME | MOUSE MODEL | MYOSTATIN | TRANSFORMING-GROWTH-FACTOR | DIFFERENTIATION | EXPRESSION | Antibodies - therapeutic use | Fibrillin-1 | Muscular Dystrophy, Duchenne - drug therapy | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Losartan - pharmacology | Fibrillins | Muscle, Skeletal - physiology | Mutation - genetics | Regeneration - physiology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Antibodies - pharmacology | Regeneration - drug effects | Animals | Marfan Syndrome - drug therapy | Analysis of Variance | Signal Transduction - drug effects | Fluorescent Antibody Technique | Histocytochemistry | Losartan - therapeutic use | Mice | Microfilament Proteins - genetics | Transforming Growth Factor beta - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II
by Iwanaga, Koji and Komuro, Issei and Takano, Hiroyuki and Tamura, Koichi and Umemura, Satoshi and Fujita, Toshiro and Toko, Haruhiro and Fukamizu, Akiyoshi and Kudoh, Sumiyo and Nagai, Toshio and Zhu, Weidong and Makita, Noriko and Sano, Masanori and Qin, Yingjie and Kihara, Minoru and Zou, Yunzeng and Akazawa, Hiroshi and Minamino, Tohru and Iiri, Taroh
Nature Cell Biology, ISSN 1465-7392, 06/2004, Volume 6, Issue 6, pp. 499 - 506
The angiotensin II type 1 (AT1) receptor has a crucial role in load-induced cardiac hypertrophy. Here we show that the AT1 receptor can be activated by... 
MYOCYTES IN-VITRO | PRESSURE-OVERLOAD | AT RECEPTOR | PROTEIN-COUPLED RECEPTORS | RANDOMIZED-TRIAL | INDUCED CARDIOMYOCYTE HYPERTROPHY | INDUCED CARDIAC-HYPERTROPHY | CULTURED-CELLS | KNOCKOUT MICE | LEFT-VENTRICULAR HYPERTROPHY | CELL BIOLOGY | Tetrazoles - pharmacology | Rats, Wistar | Protein-Tyrosine Kinases - metabolism | Humans | Stress, Mechanical | Protein Transport - physiology | Protein Transport - drug effects | Janus Kinase 2 | Angiotensin II Type 1 Receptor Blockers | Up-Regulation - physiology | Phosphatidylinositols - metabolism | Proto-Oncogene Proteins | Angiotensin II - metabolism | Cardiomegaly - physiopathology | Rats | Mice, Knockout | Animals | Muscle Contraction - physiology | Receptor, Angiotensin, Type 1 - metabolism | Myocytes, Cardiac - metabolism | Benzimidazoles - pharmacology | Cytosol - metabolism | Mice | COS Cells | Cardiomegaly - metabolism | GTP-Binding Proteins - metabolism | Mitogen-Activated Protein Kinases - metabolism | Receptors | Heart cells | Angiotensin | Physiological aspects | Genetic aspects | Research | Heart diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss
by Giral, M and Foucher, Y and Dufay, A and Van Huyen, J. P. D and Renaudin, K and Moreau, A and Philippe, A and Hegner, B and Dechend, R and Heidecke, H and Brouard, S and Cesbron, A and Castagnet, S and Devys, A and Soulillou, J. P and Dragun, D
American Journal of Transplantation, ISSN 1600-6135, 10/2013, Volume 13, Issue 10, pp. 2567 - 2576
The angiotensin II type 1 receptor (AT1R) is an emerging target of functional non‐HLA antibodies (Ab). We examined the potential of determining the degree of... 
antibody mediated rejection | Acute allograft rejection | angiotensin II receptors | pretransplant | survival | allosensitization | SURGERY | ACTIVATION | ANTIGENS | RECIPIENTS | TRANSPLANTATION | RENAL-ALLOGRAFT REJECTION | IMPACT | ALLOANTIBODIES | FLOW-CYTOMETRY | HLA ANTIBODIES | Acute Disease | Graft Survival - immunology | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Follow-Up Studies | Autoantibodies - blood | Humans | Middle Aged | HLA Antigens - immunology | Male | Kidney Transplantation | Graft Rejection - diagnosis | Preoperative Care | Transplantation, Homologous | Autoantibodies - immunology | Adult | Female | Kidney Diseases - surgery | Transplantation Immunology | Kidney Diseases - blood | Graft Rejection - immunology | Receptor, Angiotensin, Type 1 - immunology | Graft Rejection - blood | Angiotensin | Transplants & implants | Liver | Angiotensin II | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor–Mediated Cardiomyocyte Autophagy
by Porrello, Enzo R and DʼAmore, Angelo and Curl, Claire L and Allen, Andrew M and Harrap, Stephen B and Thomas, Walter G and Delbridge, Lea M.D
Hypertension, ISSN 0194-911X, 06/2009, Volume 53, Issue 6, pp. 1032 - 1040
Autophagy has emerged as an important process in the pathogenesis of cardiovascular diseases, but the proximal triggers for autophagy are unknown. Angiotensin... 
Angiotensin II type 1 receptor | Hypertrophic heart rat | Neonate | Angiotensin II type 2 receptor | Angiotensin II | Autophagy | Hypertrophy | autophagy | RAT | hypertrophic heart rat | hypertrophy | neonate | angiotensin II type 1 receptor | QUANTITATIVE PHASE MICROSCOPY | HEART | angiotensin II type 2 receptor | angiotensin II | GROWTH | PERIPHERAL VASCULAR DISEASE | LIGAND | EXPRESSION | Animals, Newborn | Gene Transfer Techniques | Receptor, Angiotensin, Type 2 - genetics | Cells, Cultured | RNA, Messenger - analysis | Rats | Cardiomegaly - pathology | Reference Values | Autophagy - physiology | Random Allocation | Rats, Sprague-Dawley | Myocytes, Cardiac - pathology | Receptor, Angiotensin, Type 1 - genetics | Animals | Receptor, Angiotensin, Type 2 - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Sensitivity and Specificity | Adenoviridae - genetics | Myocytes, Cardiac - metabolism | Female | Autophagy - genetics | Cardiomegaly - metabolism | Disease Models, Animal | Mitogen-Activated Protein Kinases - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights